Pediatric Hematology/Oncology and ImmunopathologyPediatric Hematology/Oncology and ImmunopathologyВопросы гематологии/онкологии и иммунопатологии в педиатрии1726-17082414-9314Fund Doctors, Innovations, Science for Children65810.24287/j.658SCHOOL ON TRANSPLANTATION AND CELLUL AR THERAPYШКОЛА ПО ТРАНСПЛАНТАЦИИ И КЛЕТОЧНОЙ ТЕРАПИИHematopoietic stem cell transplantation: preparation treatment, graft characteristics, criteria of engraftment, and supportive careТрансплантация гемопоэтических стволовых клеток: подготовительная терапия, характеристики трансплантата, критерии приживления и сопроводительная терапияhttps://orcid.org/0000-0003-2689-0569BalashovD. N.БалашовД. Н.Russian Federation
1. Thomas E.D., Storb R. Technique for human marrow grafting. Blood 1970; 36: 507–15Thomas E.D., Storb R. Technique for human marrow grafting. Blood 1970; 36: 507–152. Kuittinen T., Nousiainen T., Halonen P., Mahlama ̈ki E., Jantunen E. Prediction of mobilization failure in patients with non-Hodgkin’s lymphoma. Bone Marrow Transplant 2004; 33 (9): 907–12. DOI: 10.1038/sj.bmt.1704466Kuittinen T., Nousiainen T., Halonen P., Mahlama ̈ki E., Jantunen E. Prediction of mobilization failure in patients with non-Hodgkin’s lymphoma. Bone Marrow Transplant 2004; 33 (9): 907–12. DOI: 10.1038/sj.bmt.17044663. Ferraro F., Lymperi S., Mendez-Ferrer S., Saez B., Spencer J.A., Yeap B.Y., et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011; 3 (104): 104ra101. DOI: 10.1126/scitranslmed.3002191Ferraro F., Lymperi S., Mendez-Ferrer S., Saez B., Spencer J.A., Yeap B.Y., et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011; 3 (104): 104ra101. DOI: 10.1126/scitranslmed.30021914. Fowler C.J., Dunn A., Hayes-Lattin B., Hansen K., Hansen L., Lanier K., et al. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplant 2009; 43: 909–17. DOI: 10.1038/bmt.2008.409Fowler C.J., Dunn A., Hayes-Lattin B., Hansen K., Hansen L., Lanier K., et al. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplant 2009; 43: 909–17. DOI: 10.1038/bmt.2008.4095. Sinha S., Gastineau D., Micallef I., Hogan W., Ansell S., Buadi F., et al. Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplant 2011; 46: 943–9. DOI: 10.1038/bmt.2010.236Sinha S., Gastineau D., Micallef I., Hogan W., Ansell S., Buadi F., et al. Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplant 2011; 46: 943–9. DOI: 10.1038/bmt.2010.2366. Балашов Д.Н., Курникова Е.Е., Масчан М.А., Скворцова Ю.В., Шелихова Л.Н., Трахтман П.Е. и др. Применение плериксафора для мобилизации гемопоэтиче ских стволовых клеток у доноров аллогенного трансплантата. Онкогематология 2014; 9 (4): 24–7.Балашов Д.Н., Курникова Е.Е., Масчан М.А., Скворцова Ю.В., Шелихова Л.Н., Трахтман П.Е. и др. Применение плериксафора для мобилизации гемопоэтиче ских стволовых клеток у доноров аллогенного трансплантата. Онкогематология 2014; 9 (4): 24–7.7. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974; 43 (3): 357–61.Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974; 43 (3): 357–61.8. Prindull G., Prindull B., Meulen N. Haematopoietic stem cells (CFUc) in human cord blood. Acta Paediatr Scand 1978; 67 (4): 413–6. DOI: 10.1111/j.1651-2227.1978.tb16347.xPrindull G., Prindull B., Meulen N. Haematopoietic stem cells (CFUc) in human cord blood. Acta Paediatr Scand 1978; 67 (4): 413–6. DOI: 10.1111/j.1651-2227.1978.tb16347.x9. Fauser A.A., Messner H.A. Granuloerythropoietic colonies in human bone marrow. peripheral blood and cord blood. Blood 1978; 52 (6): 1243–8.Fauser A.A., Messner H.A. Granuloerythropoietic colonies in human bone marrow. peripheral blood and cord blood. Blood 1978; 52 (6): 1243–8.10. Hassan M.W., Lutton J.D., Levere R.D., Rieder R.F., Cederqvist L.L. In vitro culture of erythroid colonies from human fetal liver and umbilical cord blood. Br J Haematol 1979; 41 (4): 477–84. DOI: 10.1111/j.1365-2141.1979.tb05885.xHassan M.W., Lutton J.D., Levere R.D., Rieder R.F., Cederqvist L.L. In vitro culture of erythroid colonies from human fetal liver and umbilical cord blood. Br J Haematol 1979; 41 (4): 477–84. DOI: 10.1111/j.1365-2141.1979.tb05885.x11. Rowley S.D. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992; 1 (3): 233–50. DOI: 10.1089/scd.1.1992.1.233Rowley S.D. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992; 1 (3): 233–50. DOI: 10.1089/scd.1.1992.1.23312. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29 (7): 545–52. DOI: 10.1038/sj.bmt.1703389Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29 (7): 545–52. DOI: 10.1038/sj.bmt.170338913. Teltschik H.-M., Heinzelmann F., Gruhn B., Feuchtinger Т., Schlegel Р., Schumm М., et al. Treatment of graft failure with TNI-based reconditioning and haploidentical stem paediatric patients. Br J Haematol 2016; 175 (1): 115–22. DOI: 10.1111/bjh.14190Teltschik H.-M., Heinzelmann F., Gruhn B., Feuchtinger Т., Schlegel Р., Schumm М., et al. Treatment of graft failure with TNI-based reconditioning and haploidentical stem paediatric patients. Br J Haematol 2016; 175 (1): 115–22. DOI: 10.1111/bjh.1419014. Worel N., Greinix H.T., Schneider B., Kurz М., Rabitsch W., Knöbl Р., et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000; 40 (5): 543–50. DOI: 10.1046/j.1537-2995.2000.40050543.xWorel N., Greinix H.T., Schneider B., Kurz М., Rabitsch W., Knöbl Р., et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000; 40 (5): 543–50. DOI: 10.1046/j.1537-2995.2000.40050543.x15. Bowden R.A., Sayers M., Gleaves C.A., Banaji М., Newton В., Meyers J.D. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion 1987; 27 (6): 478–81. DOI: 10.1046/j.1537-2995.1987.27688071699.xBowden R.A., Sayers M., Gleaves C.A., Banaji М., Newton В., Meyers J.D. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion 1987; 27 (6): 478–81. DOI: 10.1046/j.1537-2995.1987.27688071699.x16. Narvios A.B., de Lima M., Shah H., Lichtiger B. Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients. Bone Marrow Transplant 2005; 36 (6): 499–501.Narvios A.B., de Lima M., Shah H., Lichtiger B. Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients. Bone Marrow Transplant 2005; 36 (6): 499–501.17. Балашов Д.Н., Трахтман П.Е. Особенности проведения трансфузионной терапии у пациентов после трансплантации гемопоэтических стволовых клеток. Обзор литературы. Онкогематология 2013; 8 (3):42–7.Балашов Д.Н., Трахтман П.Е. Особенности проведения трансфузионной терапии у пациентов после трансплантации гемопоэтических стволовых клеток. Обзор литературы. Онкогематология 2013; 8 (3):42–7.18. Dorobyski W.R., Szabo A., Zhu F., Keever-Taylor C., Hebert K.M., Dunn R., et al. Tocilizumab, tacrolimus and methotrexate for prevention of acute graft-versushost disease: low incidence of lower gastrointestinal tract disease. Haematologica 2018; 103 (4): 717–27. DOI: 10.3324/haematol.2017.183434Dorobyski W.R., Szabo A., Zhu F., Keever-Taylor C., Hebert K.M., Dunn R., et al. Tocilizumab, tacrolimus and methotrexate for prevention of acute graft-versushost disease: low incidence of lower gastrointestinal tract disease. Haematologica 2018; 103 (4): 717–27. DOI: 10.3324/haematol.2017.18343419. Радыгина С.А., Васильева А.П., Козловская С.Н., Шипицына И.П., Лившиц А.М., Гутовская Е.И. и др. Оценка эффективности использования абатацепта для профилактики острой реакции трансплантат против хозяина после трансплантации гемопоэтических стволовых клеток у детей с незлокачественными заболеваниями. Вопросы гематологии/ онкологии и иммунопатологии в педиатрии 2019; 18 (2): 22–9. DOI: 10.24287/1726-1708-2019-18-2-22-29Радыгина С.А., Васильева А.П., Козловская С.Н., Шипицына И.П., Лившиц А.М., Гутовская Е.И. и др. Оценка эффективности использования абатацепта для профилактики острой реакции трансплантат против хозяина после трансплантации гемопоэтических стволовых клеток у детей с незлокачественными заболеваниями. Вопросы гематологии/ онкологии и иммунопатологии в педиатрии 2019; 18 (2): 22–9. DOI: 10.24287/1726-1708-2019-18-2-22-2920. Luznik L., Fuchs E.J. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 2010 47: 65–77.Luznik L., Fuchs E.J. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 2010 47: 65–77.21. Caselli D., Cesaro S., Fagioli F., Carraro F., Ziino О., Zanazzo G., et al. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy. Infect Dis (Lond) 2016; 48: 152–5.Caselli D., Cesaro S., Fagioli F., Carraro F., Ziino О., Zanazzo G., et al. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy. Infect Dis (Lond) 2016; 48: 152–5.22. Lehrnbecher T., Robinson P., Fisher B., Alexander S., Ammann R.A., Beauchemin М., et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol 2017; 35: 2082–94.Lehrnbecher T., Robinson P., Fisher B., Alexander S., Ammann R.A., Beauchemin М., et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol 2017; 35: 2082–94.23. Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091–100.Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091–100.24. [Электронный ресурс] URL: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm. Дата обращения 12.08.2022.[Электронный ресурс] URL: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm. Дата обращения 12.08.2022.25. Балашов Д.Н. Актуальность и методы коррекции вторичной гипогаммаглобулинемии в клинической практике. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019; 18 (3): 145–53.Балашов Д.Н. Актуальность и методы коррекции вторичной гипогаммаглобулинемии в клинической практике. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019; 18 (3): 145–53.